Visual performance and patient-reported outcomes of a non-apodized diffractive trifocal intraocular lens in Chinese cataract patients: a prospective multicenter real-world study - Scorecard - MDSpire

Visual performance and patient-reported outcomes of a non-apodized diffractive trifocal intraocular lens in Chinese cataract patients: a prospective multicenter real-world study

  • By

  • Yan Wen

  • Qiong Liao

  • Shuai Chen

  • Maosheng Chen

  • Xiaocheng Zhang

  • Lei Wu

  • Zhengdong Xu

  • Li An

  • Jilin Tan

  • July 8, 2026

  • 0 min

Share

Clinical Scorecard: Evaluation of Visual Outcomes and Patient Satisfaction with a Non-Apodized Diffractive Trifocal Intraocular Lens in Chinese Patients with Cataracts: A Prospective Multicenter Study

At a Glance

CategoryDetail
ConditionCataracts
Key MechanismsBilateral implantation of a non-apodized diffractive trifocal intraocular lens (IOL) designed to provide distance, intermediate, and near vision.
Target PopulationPatients aged ≥ 18 years with bilateral age-related or complicated cataracts.
Care SettingRoutine ophthalmic practice at tertiary eye institutions in Southwest China.

Key Highlights

  • 91.24% of patients achieved binocular visual acuity of ≤0.200 logMAR at all three distances.
  • Mean binocular UDVA, UIVA, and UNVA were 0.017 ± 0.086, 0.061 ± 0.110, and 0.061 ± 0.103 logMAR, respectively.
  • 84.62% of eyes were within ±0.50 D of emmetropia.
  • 96.90% of patients reported complete spectacle independence.
  • The study provides real-world evidence on the performance of the PanOptix IOL in a Chinese population.

Guideline-Based Recommendations

Diagnosis

  • Patients should be diagnosed with bilateral age-related or complicated cataracts.

Management

  • Bilateral implantation of the PanOptix trifocal IOL is recommended for appropriate candidates.

Monitoring & Follow-up

  • Postoperative visual acuity should be assessed at 3 months.

Risks

  • Patients with ocular comorbidities that could affect visual outcomes should be excluded from the study.

Patient & Prescribing Data

Patients aged 18 years or older undergoing cataract surgery.

The PanOptix trifocal IOL provides improved visual performance across multiple distances.

Clinical Best Practices

  • Ensure comprehensive preoperative assessment of ocular health.
  • Provide detailed patient counseling regarding expected outcomes and potential risks.
  • Monitor visual acuity and patient satisfaction postoperatively.

Related Resources & Content

Original Source(s)

Related Content